相关实验视频

Updated: Jun 30, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

422

在肝细胞癌的转化疗法过渡的预测因素使用阿特佐利祖马布加贝瓦西祖马布

Tatsuya Kikuchi1, Yasuto Takeuchi1,2, Kazuhiro Nouso3

  • 1Department of Gastroenterology and Hepatology, Okayama University Hospital, Okayama City, Japan.

Liver international : official journal of the International Association for the Study of the Liver
|March 15, 2024
PubMed
概括

巴塞罗那诊所肝癌 (BCLC) 阶段A或B预测,在治疗阿特佐利祖马布和贝瓦西祖马布后,对不可切除的肝细胞癌 (HCC) 进行成功的转化疗法. 较少的病变和较早的治疗改善了无癌症的结果.

关键词:
巴塞罗那诊所肝癌阶段这是一种α-fetoprotein.它们是Atezolizumab.这是bevacizumab的治疗方法.没有癌症的无癌症.儿童 - 皮厄斯评分转换疗法的转换疗法.肝细胞癌是肝细胞癌.现实世界的实践实践.瘤的反应反应.

更多相关视频

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.2K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K